Crossmark

A novel lysosome‐to‐mitochondria signaling pathway disrupted by amyloid‐β oligomers

Crossref DOI link: https://doi.org/10.15252/embj.2018100241

Published Online: 2018-10-22

Published Print: 2018-11-15

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Norambuena, Andrés https://orcid.org/0000-0003-2977-1709
Wallrabe, Horst

Cao, Rui

Wang, Dora Bigler

Silva, Antonia

Svindrych, Zdenek

Periasamy, Ammasi

Hu, Song

Tanzi, Rudolph E

Kim, Doo Yeon

Bloom, George S https://orcid.org/0000-0003-4781-7627
Funding

Funding for this research was provided by:

National Institutes of Health (RF1 AG051085)

National Institutes of Health (RF1 AG048080)

National Institutes of Health (R01 AG014713)

National Institutes of Health (S10 OD016446)

National Institutes of Health (R21 AG052062)

National Institutes of Health (P01 AG015379)

BrightFocus Foundation

Alzheimer's Association (ZEN‐16‐363266)

Cure Alzheimer's Fund
License Information

Version of Record valid from 2018-10-22
More Information

Publication History

Received: 2018-07-11

Accepted: 2018-09-05

Published: 2018-10-22